Clinical Trial: S9624 Ifosfamide in Treating Patients With Meningeal Tumors

Study Status: Terminated
Recruit Status: Terminated
Study Type: Interventional




Official Title: S9624: Phase II Study of Ifosfamide in Patients With Aggressive Meningeal Tumors

Brief Summary:

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.

PURPOSE: Phase II trial to study the effectiveness of ifosfamide in treating patients with meningeal tumors that have recurred or that cannot be removed surgically.